Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2′-deoxyadenosine

The Prevalence of Trichomonas vaginalis Infection among Reproductive-Age Women in the United States, 2001-2004

Madeline Y. Sutton, Maya Sternberg, Emilia H. Koumans et al. · Clinical Infectious Diseases · 2007 · 494 citations

Veterinary Medicine, Infectious Diseases, Microbiology +16

Nitazoxanide: A New Thiazolide Antiparasitic Agent

LeAnne M. Fox, Louis D. Saravolatz · Clinical Infectious Diseases · 2005 · 441 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +17

Antiparasitic Drug Nitazoxanide Inhibits the Pyruvate Oxidoreductases of <i>Helicobacter pylori</i> , Selected Anaerobic Bacteria and Parasites, and <i>Campylobacter jejuni</i>

Paul S. Hoffman, Gary Sisson, Matthew A. Croxen et al. · Antimicrobial Agents and Chemotherapy · 2006 · 242 citations · Full text

Life Sciences, Microbiology, Pharmacology +13

<i>Trichomonas vaginalis</i>: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance

David Leitsch, Daniel Kolarich, Marina Binder et al. · Molecular Microbiology · 2009 · 170 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Efficacy of Nitazoxanide against <i>Cryptosporidium parvum</i> in Cell Culture and in Animal Models

C M Theodos, Jeffrey K. Griffiths, Jennifer D’Onfro et al. · Antimicrobial Agents and Chemotherapy · 1998 · 169 citations · Full text

Life Sciences, Microbiology, Pharmacology +17